IRTC241220P55000
- 0.51
- 0.000.00%
iRhythm Technologies Newsroom
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $85
BTIG Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $120
Irhythm Technologies (IRTC) Receives a Buy From BTIG
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $95
Baird Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $79
A Quick Look at Today's Ratings for IRhythm Technologies(IRTC.US), With a Forecast Between $79 to $120
Baird Maintains Outperform on IRhythm Technologies, Lowers Price Target to $79
A Quick Look at Today's Ratings for IRhythm Technologies(IRTC.US), With a Forecast Between $85 to $125
IRhythm Technologies Analyst Ratings
IRhythm Technologies Analyst Ratings
Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $145
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $95
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Irhythm Technologies (IRTC)
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $120
Irhythm Technologies Gains Buy Rating Following Regulatory Milestones
Baird Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $100
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Announces Target Price $80
Truist Cuts Price Target on IRhythm Technologies to $80 From $117, Keeps Buy Rating
Goldman Sachs Initiates IRhythm Technologies(IRTC.US) With Hold Rating, Announces Target Price $78
IRhythm Technologies Is Maintained at Buy by Canaccord Genuity